CA988418A - Agents for inhalation therapy of bronchial diseases - Google Patents

Agents for inhalation therapy of bronchial diseases

Info

Publication number
CA988418A
CA988418A CA146,913A CA146913A CA988418A CA 988418 A CA988418 A CA 988418A CA 146913 A CA146913 A CA 146913A CA 988418 A CA988418 A CA 988418A
Authority
CA
Canada
Prior art keywords
agents
inhalation therapy
bronchial diseases
bronchial
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA146,913A
Other languages
English (en)
Other versions
CA146913S (en
Inventor
Rudolf Bauer
Helmut Wick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim GmbH
Original Assignee
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim GmbH filed Critical Boehringer Ingelheim GmbH
Application granted granted Critical
Publication of CA988418A publication Critical patent/CA988418A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA146,913A 1971-07-13 1972-07-12 Agents for inhalation therapy of bronchial diseases Expired CA988418A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2134899A DE2134899C3 (de) 1971-07-13 1971-07-13 Verwendung von N-Äthyl-norscopolaminmethobromid

Publications (1)

Publication Number Publication Date
CA988418A true CA988418A (en) 1976-05-04

Family

ID=5813500

Family Applications (1)

Application Number Title Priority Date Filing Date
CA146,913A Expired CA988418A (en) 1971-07-13 1972-07-12 Agents for inhalation therapy of bronchial diseases

Country Status (13)

Country Link
US (1) US4016279A (it)
AU (1) AU470025B2 (it)
BE (1) BE786200A (it)
CA (1) CA988418A (it)
DE (1) DE2134899C3 (it)
FR (1) FR2145693B1 (it)
GB (1) GB1392094A (it)
HK (1) HK49679A (it)
IE (1) IE36952B1 (it)
IL (1) IL39889A (it)
IT (1) IT1116880B (it)
NL (1) NL175493C (it)
ZA (1) ZA724724B (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183912A (en) * 1978-01-16 1980-01-15 American Home Products Corporation Inhalation therapy for relieving bronchial spasm using quaternary salts of promethazine
IT1164227B (it) * 1983-05-13 1987-04-08 Angeli Inst Spa Composizione farmaceutica atta alla somministrazione nasale di sali quaternari d'ammonio ed attivita' anticolinergica
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
RU2684761C1 (ru) * 2018-02-20 2019-04-12 Федеральное государственное бюджетное образовательное учреждение высшего образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СибГМУ Минздрава России) Способ профилактики респираторных осложнений у пациентов после хирургического лечения рака легкого

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2753288A (en) * 1953-01-12 1956-07-03 Upjohn Co Scopolamine lower-alkyl halide therapeutic composition
US3169095A (en) * 1962-10-30 1965-02-09 Rexall Drug Chemical Self-propelling powder-dispensing compositions
DE1670048C3 (de) * 1966-01-26 1980-09-04 C.H. Boehringer Sohn, 6507 Ingelheim Neue Norscopolaminderivate

Also Published As

Publication number Publication date
GB1392094A (en) 1975-04-23
DE2134899C3 (de) 1981-04-02
IE36952L (en) 1973-01-13
US4016279A (en) 1977-04-05
IL39889A (en) 1976-05-31
IT1116880B (it) 1986-02-10
IL39889A0 (en) 1972-09-28
NL175493C (nl) 1984-11-16
FR2145693B1 (it) 1976-03-05
NL7209675A (it) 1973-01-16
ZA724724B (en) 1974-03-27
AU4449872A (en) 1974-01-17
DE2134899A1 (de) 1973-02-01
FR2145693A1 (it) 1973-02-23
AU470025B2 (en) 1976-03-04
HK49679A (en) 1979-07-27
BE786200A (fr) 1973-01-12
IE36952B1 (en) 1977-03-30
IT7949433A0 (it) 1979-06-15
NL175493B (nl) 1984-06-18
DE2134899B2 (de) 1980-07-10

Similar Documents

Publication Publication Date Title
IL35622A0 (en) Nebulizer for inhalation therapy
AU460201B2 (en) Ultrasonic nebulizer for inhalation therapy
AU506080B2 (en) Use of flunisolide to treat respiratory diseases
GB1368201A (en) Treatment of diseases of the skin and mucosa
CA988418A (en) Agents for inhalation therapy of bronchial diseases
CA942671A (en) Inhalant compositions for treatment of obstructive diseases of the respiratory tract
ZA766303B (en) Disubstituted phenol ethers of 3-amino-2-hydroxypropane processes for their preparation and their use as medicament
MY8100159A (en) Pharmacuetical preparations for the treatment of coronary heart diseases
AU475165B2 (en) Treatment of respiration conditions using hydroxycyclohexylamino compounds
AU463836B2 (en) Composition for treatment of asthma
CA989731A (en) Treatment of heart diseases
PH16191A (en) Spray compositions for inhalation therapy of bronchial disorders
ZA763131B (en) Use of flunisolide to treat respiratory diseases
CA942666A (en) Treatment of diseases
CA945059A (en) Inhalation therapy apparatus
CA876097A (en) Processes for preparation of therapeutic serums
AU3583771A (en) A composition for the treatment of pulmonary affections by inhalation
AU283197B2 (en) Pharmaceutical compositions forthe treatment of prophylayis of heart diseases
CA653242A (en) Method for the preparation of effective substances with therapeutic power for pancreatic diseases
CA886037A (en) Therapeutic agents
CA872768A (en) Silver-containing therapeutic agents
CA649111A (en) Self-propelling compositions for inhalation therapy
CA887751A (en) Therapeutic bandaging
AU406834B2 (en) Therapeutic compositions forthe treatment of bronchial spasms
CA803253A (en) Treatment of diseases affecting the extremities